1. 1998
  2. Karakterisering van 100 patiënten met tuberculose behandeld in het Academisch Medisch Centrum te Amsterdam

    Juffermans, N., Verbon, A., van der Meer, J. T., Dankert, J., van Steenwijk, R. P. & Speelman, P., 1998, In: Nederlands tijdschrift voor geneeskunde. 142, 4, p. 180-184

    Research output: Contribution to journalArticleProfessional

  3. Mycobacterium xenopi in HIV-infected patients: an emerging pathogen

    Juffermans, N. P., Verbon, A., Danner, S. A., Kuijper, E. J. & Speelman, P., 1998, In: AIDS (London, England). 12, 13, p. 1661-1666

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis

    Juffermans, N. P., Verbon, A., van Deventer, S. J., Buurman, W. A., van Deutekom, H., Speelman, P. & van der Poll, T., 1998, In: Journal of infectious diseases. 178, 6, p. 1839-1842

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis

    Juffermans, N. P., Verbon, A., van Deventer, S. J., van Deutekom, H., Speelman, P. & van der Poll, T., 1998, In: American journal of respiratory and critical care medicine. 157, 4 Part 1, p. 1328-1331

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis

    Juffermans, N. P., Verbon, A., Van Deventer, S. J. H., Van Deutekom, H., Speelman, P. & Van Der Poll, T., 1998, In: Pneumologie. 52, 11, p. 625 1 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1...28 29 30 31 32 Next

ID: 63915